• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫性血小板减少症的脾脏组织学:临床病理特征及预后意义。

Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implications.

机构信息

Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.

3rd Surgical Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

出版信息

Eur J Haematol. 2021 Feb;106(2):281-289. doi: 10.1111/ejh.13547. Epub 2020 Dec 2.

DOI:10.1111/ejh.13547
PMID:33190299
Abstract

OBJECTIVE

Immune thrombocytopenia (ITP) is an acquired disorder, characterized by immune-mediated platelet destruction. The spleen plays a key pathogenic role in ITP and splenectomy is a valuable second-line therapy for this disease. Little is known on ITP spleen histology and response to splenectomy is unpredictable. This study aims to characterize ITP spleen histology and assess possible predictors of splenectomy outcome.

METHODS

A series of 23 ITP spleens were retrospectively assessed for the following histological parameters: density of lymphoid follicles (LFs), marginal zones (MZs), T helper and cytotoxic T cells; presence of reactive germinal centers (GCs); width of perivascular T cell sheaths; and red pulp features. Clinical and histological data were matched with postsplenectomy platelet counts to assess their prognostic relevance.

RESULTS

Three histological patterns were documented: a hyperplastic white pulp pattern, a non-activated white pulp pattern (lacking GCs), and a white pulp-depleted pattern. Poor surgical responses were associated with presplenectomy high-dose steroid administration, autoimmune comorbidities and low T follicular helper cell density. The combination of such parameters stratified patients into different splenectomy response groups. The removal of accessory spleens was also associated with better outcome.

CONCLUSION

ITP spleens are histologically heterogeneous and clinical-pathological parameters may help predict the splenectomy outcome.

摘要

目的

免疫性血小板减少症(ITP)是一种获得性疾病,其特征为免疫介导的血小板破坏。脾脏在 ITP 中起关键的致病作用,脾切除术是治疗该病的有价值的二线疗法。对于 ITP 脾脏的组织学了解甚少,且对脾切除术的反应难以预测。本研究旨在描述 ITP 脾脏的组织学特征,并评估脾切除术结果的可能预测因素。

方法

回顾性评估了 23 例 ITP 脾脏的以下组织学参数:淋巴滤泡(LFs)、边缘区(MZs)、辅助性 T 细胞和细胞毒性 T 细胞的密度;反应性生发中心(GCs)的存在;血管周围 T 细胞鞘的宽度;以及红髓特征。将临床和组织学数据与脾切除术后血小板计数相匹配,以评估其预后相关性。

结果

记录了三种组织学模式:增生性白髓模式、非激活的白髓模式(缺乏 GCs)和白髓耗竭模式。术前高剂量类固醇治疗、自身免疫合并症和滤泡辅助性 T 细胞密度低与手术反应不佳相关。这些参数的组合将患者分层为不同的脾切除术反应组。附加脾脏的切除也与更好的结果相关。

结论

ITP 脾脏在组织学上是异质的,临床病理参数可能有助于预测脾切除术的结果。

相似文献

1
Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implications.免疫性血小板减少症的脾脏组织学:临床病理特征及预后意义。
Eur J Haematol. 2021 Feb;106(2):281-289. doi: 10.1111/ejh.13547. Epub 2020 Dec 2.
2
Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.成人原发免疫性血小板减少症:基于 41 例分析的利妥昔单抗使用与脾脏组织学表现和结局的相关性。
Am J Surg Pathol. 2018 Mar;42(3):401-412. doi: 10.1097/PAS.0000000000000994.
3
Increased number of B-cells in the red pulp of the spleen in ITP.特发性血小板减少性紫癜患者脾脏红髓中 B 细胞数量增加。
Ann Hematol. 2012 Feb;91(2):271-7. doi: 10.1007/s00277-011-1292-2. Epub 2011 Jul 23.
4
Comparative study of spleen pathology in drug abusers with thrombocytopenia related to human immunodeficiency virus infection and in patients with idiopathic thrombocytopenic purpura. A morphometric, immunohistochemical, and ultrastructural study.与人类免疫缺陷病毒感染相关的血小板减少症药物滥用者与特发性血小板减少性紫癜患者脾脏病理学的比较研究。一项形态计量学、免疫组织化学和超微结构研究。
Am J Clin Pathol. 1993 Dec;100(6):633-42. doi: 10.1093/ajcp/100.6.633.
5
Secondary spleen in immune thrombocytopenia: Not so accessory after all….免疫性血小板减少症中的副脾:并非可有可无……
Br J Haematol. 2023 Jul;202(1):9-10. doi: 10.1111/bjh.18776. Epub 2023 Mar 27.
6
Accessory spleens recapitulate the immune microenvironment of the main spleen in immune thrombocytopenia.副脾重现免疫性血小板减少症主脾的免疫微环境。
Br J Haematol. 2023 Jul;202(1):147-152. doi: 10.1111/bjh.18749. Epub 2023 Mar 14.
7
Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)?脾切除术对特发性血小板减少性紫癜(ITP)患者的良好疗效是否可预测?
Surg Endosc. 2001 Dec;15(12):1386-9. doi: 10.1007/s00464-001-8154-2.
8
Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP).免疫珠试验用于诊断成人慢性免疫性血小板减少性紫癜(ITP)的前瞻性评估。
J Thromb Haemost. 2003 Mar;1(3):485-91. doi: 10.1046/j.1538-7836.2003.00091.x.
9
Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.免疫性血小板减少症:一线类固醇治疗的效果,以及作为二线治疗的硫唑嘌呤、脾切除术和利妥昔单抗的比较。
Eur J Haematol. 2018 Oct;101(4):549-555. doi: 10.1111/ejh.13144. Epub 2018 Aug 31.
10
[Quantitative and qualitative observations of spleens removed from patients].
Zhonghua Bing Li Xue Za Zhi. 1993 Aug;22(4):236-8.

引用本文的文献

1
The Prognostic Value of Platelet Kinetics Assessment in Pediatric Chronic Idiopathic Thrombocytopenic Purpura.血小板动力学评估在儿童慢性特发性血小板减少性紫癜中的预后价值
Diagnostics (Basel). 2025 Jul 16;15(14):1790. doi: 10.3390/diagnostics15141790.
2
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study.免疫性血小板减少症脾切除术反应的预测因素:一项意大利多中心研究。
J Clin Med. 2024 Dec 25;14(1):30. doi: 10.3390/jcm14010030.
3
Evidence on the therapeutic role of thiolutin in imiquimod-induced psoriasis-like skin inflammation in mice.
硫辛酰胺在咪喹莫特诱导的小鼠银屑病样皮肤炎症中的治疗作用的证据。
Immun Inflamm Dis. 2023 Jul;11(7):e877. doi: 10.1002/iid3.877.
4
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.ETV6高水平支持侵袭性B淋巴瘤细胞存活并预示弥漫性大B细胞淋巴瘤患者预后不良。
Cancers (Basel). 2022 Jan 11;14(2):338. doi: 10.3390/cancers14020338.